NewAmsterdam Pharma Company NAMS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's earnings yield?
- NewAmsterdam Pharma Company (NAMS) reported earnings yield of -5.8% in Q1 2026.
- How has NewAmsterdam Pharma Company's earnings yield changed year-over-year?
- NewAmsterdam Pharma Company's earnings yield increased by 30.6% year-over-year, from -8.3% to -5.8%.
- What is the long-term trend for NewAmsterdam Pharma Company's earnings yield?
- Over 4 years (2021 to 2025), NewAmsterdam Pharma Company's earnings yield has grown at a 1.8% compound annual growth rate (CAGR), from -4.8% to -5.1%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.